497068-73-2

Basic information

• Product Name: TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE
• Synonyms: TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE
• CAS NO: 497068-73-2
• Molecular Formula: C₁₄H₁₉NO₃
• Molecular Weight: 249.31
• Mol File: 497068-73-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE(497068-73-2)
• EPA Substance Registry System: TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE(497068-73-2)

Safety Data

• Hazardous Substances Data: 497068-73-2(Hazardous Substances Data)

Usage

Description

TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE is a chemical compound that belongs to the class of dihydroquinoline carboxylates. It is commonly used in the pharmaceutical industry due to its potential therapeutic properties, such as acting as an antioxidant and an inhibitor of lipid peroxidation. The presence of the tert-butyl group enhances the compound's stability and solubility in organic solvents, making it suitable for drug formulation. The hydroxy group and the dihydroquinoline ring structure are also believed to contribute to its biological activity. Further research is required to fully understand its pharmacological and therapeutic potential.

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE is used as a pharmaceutical compound for its potential therapeutic properties, including its antioxidant and lipid peroxidation inhibitory effects. Its stability and solubility, attributed to the tert-butyl group, make it suitable for drug formulation.
Used in Neurodegenerative Disorder Treatment:
In the field of neurodegenerative disorders, TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE may be utilized as a potential therapeutic agent due to its antioxidant properties, which could help in the treatment and management of such conditions.
Used in Cardiovascular Disease Treatment:
TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE may also have applications in the development of drugs for the treatment of cardiovascular diseases, given its potential to inhibit lipid peroxidation, which can contribute to the prevention or treatment of such conditions.

Upstream product

• 6931-19-7 5-methoxyquinoline 
• 30389-37-8 5-methoxy-1,2,3,4-tetrahydroquinoline 
• 24424-99-5 di-tert-butyl dicarbonate 
• 61468-43-7 5-hydroxy-1,2,3,4-tetrahydroquinoline 

Downstream Products

• 848086-73-7 (2-chloro-3-trifluoromethyl-benzyl)-(2,2-diphenyl-ethyl)-[3-(1,2,3,4-tetrahydro-quinolin-5-yloxy)-propyl]-amine 
• 848086-74-8 5{3-[(chloro-trifluoromethyl-benzyl)-diphenylethyl-amino]-propoxy}-3,4-dihydro-2H-quinoline-1-carboxylic acid ter-butyl ester 

Relevant articles and documents

Synthesis and SAR of novel histamine H3 receptor antagonists

The synthesis and biological evaluation of novel tetrahydroisoquinoline, tetrahydroquinoline, and tetrahydroazepine antagonists of the human and rat H3 receptors are described. The substitution around these rings as well as the nature of the substituent on nitrogen is explored. Several compounds with high affinity and selectivity for the human and rat H3 receptors are reported.

HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATON AND THERAPEUTIC USES

The present invention discloses novel compounds of Formula ( I ) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention disclo